Jenny Kobin | Head, Investor Relations |
George Lasezkay | President & Chief Executive Officer |
Thomas Ciulla | Chief Medical Officer & Chief Development Officer |
Charles Deignan | Chief Financial Officer |
Boris Peaker | Cowen |
Jonathan Wolleben | JMP Securities |
Zegbeh Jallah | Roth Capital Partners |
Good afternoon ladies and gentlemen and welcome to the Clearside Biomedical Second Quarter 2020 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host speaker Jenny Kobin, Investor Relations for Clearside.